Clinical Trials Directory

Trials / Unknown

UnknownNCT03126058

Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study (ERASC1)

Enhanced Recovery After Surgery Program for Colorectal Cancer: a Multi-center Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
1,000 (estimated)
Sponsor
Jinling Hospital, China · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.

Detailed description

In China, Europe and America, colorectal cancer is one of common malignant tumors. It is very important for treatment of colorectal cancer to enhance the quality of treatment, increase patients' survival rate and improve the life quality. So far, surgical resection is optimal treatment for patients with colorectal cancer. As a result, increasing the quality of surgery and improving the perioperative managements have a great influence on patients received a coloproctectomy. Investigators have spent over ten years studying enhanced recovery after surgery programs for colorectal cancer and have got some successful experience. Investigators found enhanced recovery after surgery can accelerate patients' recovery without increasing complications. This study is the first multi-center study of enhanced recovery after surgery for colorectal cancer in China. During this period, the study is aimed to evaluate the safety of applying enhanced recovery after surgery for colorectal cancer.

Conditions

Interventions

TypeNameDescription
PROCEDUREenhanced recovery after surgeryPatients will undergo enhanced recovery after surgery programs.

Timeline

Start date
2017-06-21
Primary completion
2018-08-31
Completion
2018-12-31
First posted
2017-04-24
Last updated
2018-04-30

Locations

23 sites across 1 country: China

Source: ClinicalTrials.gov record NCT03126058. Inclusion in this directory is not an endorsement.